Several US hospitals using HCQ in treatment of COVID 19 patients: Report

MDedge, a medical publication, on Friday reported that hydroxychloroquine (HCQ) is currently the first-line therapy and Tocilizumab the second-line medication for people hospitalized with polymerase chain reaction-confirmed COVID-19 infection in the Yale New Haven Health System, which operates hospitals across Connecticut.

from International-News-Economic Times https://ift.tt/3bRqI7L
via IFTTT

SHARE